Vie Forward Looking News Today : Breaking News, Live Updates & Top Stories | Vimarsana

AbbVie and Caribou Biosciences Announce Collaboration and License Agreement for CAR-T Cell Products
ABBVie and Caribou Biosciences, Inc., a leading clinical-stage CRISPR genome editing biotechnology company, announced today that they have entered into a collaboration and license agreement for the research and development of chimeric antigen receptor -T cell therapeutics. Although allogeneic, “off-the-shelf” CAR-T cell therapies have shown early promise in some cancer patients, the need for overcoming the rejection …
– ABBVie (NYSE: ABBV) and Caribou Biosciences, Inc., a leading clinical-stage CRISPR genome editing biotechnology company, announced today that they have entered into a collaboration and license agreement for the research and development of chimeric antigen receptor (CAR)-T cell therapeutics. Although allogeneic, “off-the-shelf” CAR-T cell therapies have shown early promise in some cancer patients, the need for overcoming the rejection of allogenei ....

Steve Davidsen , Rachel Haurwitz , Caribou Biosciences Inc , Company Cariboubio , Caribou Biosciences , Chief Executive Officer , Vice President , Oncology Discovery , Allergan Aesthetics , Vie Forward Looking , ஸ்டீவ் டேவிட்ஸன் , கரிபூ உயிர் அறிவியல் இன்க் , கரிபூ உயிர் அறிவியல் , தலைமை நிர்வாகி அதிகாரி , துணை ப்ரெஸிடெஂட் , புற்றுநோயியல் கண்டுபிடிப்பு , ஒவ்வாமை அழகுணர்ச்சி , வை முன்னோக்கி பார்க்கிறது ,